Kanazawa, Ishikawa Prefecture, Japan In 1931 was created Shibuya Kogyo, which is appeared as Corporate Investor. The venture was found in Asia in Japan. The leading representative office of defined Corporate Investor is situated in the Kanazawa.
Among the most popular fund investment industries, there are Therapeutics, Medical. Among the various public portfolio startups of the fund, we may underline Promethera Biosciences, Cyfuse Biomedical, Healios K.K The fund has exact preference in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Japan. Besides, a startup needs to be aged 4-5 years to get the investment from the fund.
The usual cause for the fund is to invest in rounds with 3 partakers. Despite the Shibuya Kogyo, startups are often financed by Shire, Mitsui Global Investment, Boehringer Ingelheim Venture Fund. The meaningful sponsors for the fund in investment in the same round are tella, Shinsei Corporate Investment Limited, Shin Nippon Biomedical Laboratories (SNBL). In the next rounds fund is usually obtained by Sansei Capital Investment, SMBC Venture Capital, SBI Investment.
Opposing the other organizations, this Shibuya Kogyo works on 4 percentage points more the average amount of lead investments. The fund is constantly included in less than 2 deals per year. The common things for fund are deals in the range of 10 - 50 millions dollars. The increased amount of exits for fund were in 2015. The important activity for fund was in 2018. Considering the real fund results, this Corporate Investor is 47 percentage points more often commits exit comparing to other organizations.
Related Funds
| Fund Name | Location |
| Circus Future | - |
| Crescent Enterprises Venture Capital | Sharjah, Sharjah Emirate, United Arab Emirates |
| First Round | Finland, Riihimäki, Southern Finland |
| Granger Management LLC | - |
| Korea Information Certificate Authority (KICA) | - |
| Kvika | Gullbringusysla, Iceland, Reykjavík |
| Leeway Ventures | England, London, United Kingdom |
| Liangcang Accelerator | China, Hangzhou, Zhejiang |
| Miller Center for Social Entrepreneurship | California, Santa Clara, United States |
| Musketeer Capital | Haverford, Pennsylvania, United States |
| Panthera Capital Ventures | Dubai, United Arab Emirates |
| Rongyin Capital | Beijing, China, Haidian |
| Shanghai Houting Management Consulting | China, Shanghai |
| The Eleos Foundation | California, Santa Barbara, United States |
| Thominvest | Finland, Helsinki, Southern Finland |
| TIM | Italy, Lazio, Roma |
| Topfonds Gelderland | - |
| V-Capital | China, Shanghai |
| Vilitas GmbH & Co. KG | Aachen, Germany, Nordrhein-Westfalen |
| zkValidator | - |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Noile-Immune Biotech | $21M | 22 Mar 2021 | Chiyoda, Japan | ||
Heartseed | $7M | 30 Jul 2018 | Japan, Chiyoda | ||
| $12M | 02 Mar 2015 | Chiyoda, Japan |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Noile-Immune Biotech | $21M | 22 Mar 2021 | Chiyoda, Japan | ||
Heartseed | $7M | 30 Jul 2018 | Japan, Chiyoda | ||
| $12M | 02 Mar 2015 | Chiyoda, Japan |
